Processa Pharmaceuticals, Inc.
SEC CIK 1533743 · PCSA · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Yorke Justin W | Director | filed 2020 - 2026 |
| Neal James R | Director | filed 2022 - 2026 |
| Baluch Khoso | Director | filed 2022 - 2026 |
| Pannu Geraldine | Director | filed 2020 - 2026 |
| Young David | Director · President & CEO | filed 2020 - 2026 |
| Ng George K | Director · Chief Executive Officer | filed 2023 - 2026 |
| Thompson Virgil | Director | filed 2020 - 2023 |
| Islam Khalid | Director | filed 2020 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Skibsted Russell | Chief Financial Officer | filed 2024 - 2026 |
| Guy Wendy | Chief Administrative Officer | filed 2020 - 2026 |
| Lin Patrick | Chief Business - Strategy Off | filed 2020 - 2026 |
| Bigora Sian | Chief Development Officer | filed 2020 - 2026 |
| Stanker James H | Chief Financial Officer | filed 2020 - 2024 |
| Floyd Robert Michael | Chief Operating Officer | filed 2020 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.